These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28973705)

  • 1. Identification and Management of
    Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
    South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne.
    Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
    Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
    Grill S; Ramser J; Hellebrand H; Pfarr N; Boxberg M; Brambs C; Ditsch N; Meindl A; Groß E; Meitinger T; Kiechle M; Quante AS
    Arch Gynecol Obstet; 2021 Jun; 303(6):1557-1567. PubMed ID: 33245408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre.
    Butz H; Bozsik A; Grolmusz V; Szőcs E; Papp J; Patócs A
    Sci Rep; 2023 Aug; 13(1):14259. PubMed ID: 37653074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer.
    Huang X; Chen C; Lin Y; Wang C; Zhou X; Xu Y; Sun Q; Zhou Y
    Breast Cancer Res Treat; 2024 Aug; 206(3):653-666. PubMed ID: 38878125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
    Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
    BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Fortuno C; Richardson M; Pesaran T; Yussuf A; Horton C; James PA; Spurdle AB
    J Med Genet; 2023 Nov; 60(12):1215-1217. PubMed ID: 37536919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the
    Sandoval RL; Masotti C; de Macedo MP; Ribeiro MFSA; Leite ACR; Meireles SI; Bovolin RM; Santini FC; Munhoz RR; Jardim DLF; Katz A; Camargo AA; Fernandes GDS; Achatz MI
    JCO Glob Oncol; 2021 Jul; 7():1141-1150. PubMed ID: 34270331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Risks Associated With
    Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
    JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome.
    Gao F; Pan X; Dodd-Eaton EB; Recio CV; Montierth MD; Bojadzieva J; Mai PL; Zelley K; Johnson VE; Braun D; Nichols KE; Garber JE; Savage SA; Strong LC; Wang W
    Genome Res; 2020 Aug; 30(8):1170-1180. PubMed ID: 32817165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
    van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
    Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of TP53 mosaic variants found on germline genetic testing.
    Ward A; Farengo-Clark D; McKenna DB; Safonov A; Good M; Le A; Kessler L; Shah PD; Bradbury AR; Domchek SM; Nathanson KL; Powers J; Maxwell KN
    Cancer Genet; 2024 Jun; 284-285():43-47. PubMed ID: 38677009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic malignancies in Li-Fraumeni syndrome: A case report.
    Bundrant B; Gerstein Y; Arun B; DiNardo CD
    Am J Med Genet A; 2024 Jul; 194(7):e63573. PubMed ID: 38410872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.
    de Andrade KC; Strande NT; Kim J; Haley JS; Hatton JN; Frone MN; Khincha PP; Thone GM; Mirshahi UL; Schneider C; Desai H; Dove JT; Smelser DT; ; ; Levine AJ; Maxwell KN; Stewart DR; Carey DJ; Savage SA
    HGG Adv; 2024 Jan; 5(1):100242. PubMed ID: 37777824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited
    Guha T; Malkin D
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28270529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study).
    Packwood K; Martland G; Sommerlad M; Shaw E; Moutasim K; Thomas G; Bateman AC; Jones L; Haywood L; Evans DG; Birch JM; Alsalmi OA; Henderson A; Poplawski N; Eccles DM
    J Pathol Clin Res; 2019 Jul; 5(3):189-198. PubMed ID: 31041842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
    Kwong A; Shin VY; Ho CYS; Au CH; Slavin TP; Weitzel JN; Chan TL; Ma ESK
    BMC Cancer; 2020 Nov; 20(1):1053. PubMed ID: 33138793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic
    Bancroft EK; Saya S; Brown E; Thomas S; Taylor N; Rothwell J; Pope J; Chamberlain A; Page E; Benafif S; Hanson H; Dias A; Mikropoulos C; Izatt L; Side L; Walker L; Donaldson A; Cook JA; Barwell J; Wiles V; Limb L; Eccles DM; Leach MO; Shanley S; Gilbert FJ; Gallagher D; Rajashanker B; Whitehouse RW; Koh DM; Sohaib SA; Evans DG; Eeles RA; Walker LG
    J Med Genet; 2020 Apr; 57(4):226-236. PubMed ID: 31719169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features of Li-Fraumeni Syndrome in Korea.
    Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
    Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.